ZMUni Compliance Centre

On September 20, 2026, China's General Administration of Customs of China (GACC) released information on food products denied entry at Chinese ports in August 2026.   According to the data, 755 batches of food products that failed to meet safety, hygiene, or other relevant requirements and were therefore denied entry, representing an approximately 55% month-on-month increase from 487 batches in July 2026, an increase of 268 batches. The figure also increased by approximately 22% year-on-year, compared with 617 batches during the same period last year.   The 755 batches covered a wide range of product categories, including beverages, alcoholic beverages,

  From September 1 to 17, a total of seven new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not yet been publicly disclosed.     Shikimic acid   Shikimic acid is a naturally occurring organic acid. IIt is widely found in plants, particularly in the fruits of Illicium species such as star anise. In the pharmaceutical field, shikimic acid is of significant value as a key starting material for the synthesis of the anti-influenza drug oseltamivir (brand name: Tamiflu). With the development of biotechnology, microbial fermentation has gradually

Cross-border e-commerce (CBEC) has made it easier for overseas dietary supplement brands to reach Chinese consumers without following the conventional import and market-entry route. However, CBEC does not remove the need to meet applicable Chinese requirements.   For products containing novel, functional, or otherwise sensitive ingredients, compliance considerations may arise across ingredient status, formulation, import documentation, labeling, online claims, and post-import operations.   In other words, a product legally sold as a dietary supplement in another country cannot necessarily be marketed in China through CBEC in the same way.     Ingredient Status Is Often the Starting Point    For

On September 1, 2026, China's General Administration of Customs of China (GACC) released information on food products denied entry at Chinese ports in July 2026.   According to the data, 487 batches of imported food were denied entry in July due to non-compliance with food safety, hygiene, and other requirements. This represented an approximately 11% month-on-month decrease from the 548 batches recorded in June, but an approximately 2% year-on-year increase from the 476 batches recorded in July 2025.   The 487 rejected batches covered a wide range of product categories, including coffee, frozen meat, poultry and aquatic products, edible oils,

  In August, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA), significantly fewer than in previous months. The technical requirements for all related NCIs have not yet been publicly disclosed.     Camellia Petelotii Callus   Camellia petelotii is a species of the genus Camellia in the family Theaceae, mainly distributed in southern Guangxi, China, with limited distribution in Yunnan, Guangdong, and other regions.   Since 2021, related Camellia chrysantha ingredients have been notified nine times. This marks the first notification of Camellia petelotii callus.   The notifier, Hangzhou Shicang Xinya Biotechnology

Ampoules, vials, and syringe-type containers—packaging formats commonly associated with pharmaceutical and injectable products—are increasingly used for cosmetic products such as serums and concentrated skincare treatments. However, these formats may be subject to regulatory considerations beyond those applicable to conventional cosmetics, as their appearance can create a risk of consumer misunderstanding or misuse.   Thailand is one market where this distinction is particularly important. The Thai Food and Drug Administration (Thai FDA) has established specific requirements for cosmetic products packaged in ampoules, vials, or syringe-type containers, covering their intended use, packaging, labeling, and supporting documentation. In this article, ZMUni Compliance Centre

On July 2, 2026, the State Administration for Market Regulation (SAMR) and the Standardization Administration of China (SAC) approved 508 recommended national standards and one amendment. Among them is GB/T 29602-2026 Quality Requirements for Solid Beverages (hereinafter referred to as GB/T 29602-2026).   Developed under the leadership of the China Beverage Industry Association, GB/T 29602-2026 will take effect on August 1, 2027, replacing GB/T 29602-2013.       Overview of the Key Changes   China's solid beverage market has expanded rapidly in recent years, alongside growing concerns over unclear product definitions, blurred category boundaries, and misleading labeling and claims. GB/T

  From July 21 to 31, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not yet been publicly disclosed. Notably, four of the five notified NCIs are peptides, comprising three cyclic peptides and one polypeptide.     3'-Sialyllactose sodium salt   3'-Sialyllactose sodium salt (3'-SL) is composed of N-acetylneuraminic acid (Neu5Ac, also known as sialic acid), galactose, and glucose. As a human milk oligosaccharide (HMO), 3'-SL has been approved by authorities such as the US and EU for use in infant formula and other